Biomarkers to predict asthma in wheezing preschool children

Clinical and Experimental Allergy

Volumn 45, Issue 6, 2015, Pages 1040-1050

  Bannier, M A G E ^a   van de Kant, K D G ^a   Jobsis Q ^a   Dompeling, E ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL ADHESION MOLECULE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 8;

ASTHMA; BASEMENT MEMBRANE; BREATH ANALYSIS; BRONCHOSCOPY; CHILD; DIAGNOSTIC PROCEDURE; EOSINOPHILIA; EXPIRED AIR; GENE EXPRESSION; GENETICS; HUMAN; LUNG FUNCTION TEST; LUNG LAVAGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETICULAR BASEMENT MEMBRANE; REVIEW; WHEEZING; METABOLISM; PATHOPHYSIOLOGY; PROGNOSIS; RESPIRATORY SOUNDS;

ASTHMA; BIOMARKERS; CHILD; CHILD, PRESCHOOL; HUMANS; PROGNOSIS; RESPIRATORY SOUNDS;

EID: 84929300218     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12460     Document Type: Review

References (109)

1. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332:133-8.
2. Brand PL, Baraldi E, Bisgaard H et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32:1096-110.
3. Brand PL, Caudri D, Eber E et al. Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J 2014; 43:1172-7.
4. Spycher BD, Silverman M, Kuehni CE. Phenotypes of childhood asthma: are they real? Clin Exp Allergy 2010; 40:1130-41.
5. Ducharme FM, Tse SM, Chauhan B. Diagnosis, management, and prognosis of preschool wheeze. Lancet 2014; 383:1593-604.
6. Guilbert TW, Morgan WJ, Zeiger RS et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354:1985-97.
7. Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A, team Is. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet 2006; 368:754-62.
8. Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics 2009; 123:e519-25.
9. Clavenna A, Sequi M, Cartabia M et al. Effectiveness of nebulized beclomethasone in preventing viral wheezing: an RCT. Pediatrics 2014; 133:e505-12.
10. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162:1403-6.
11. Kurukulaaratchy RJ, Matthews S, Holgate ST, Arshad SH. Predicting persistent disease among children who wheeze during early life. Eur Respir J 2003; 22:767-71.
12. Caudri D, Wijga A, CM AS et al. Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age. J Allergy Clin Immunol 2009; 124:903-10 e1-7.
13. Savenije OE, Kerkhof M, Koppelman GH, Postma DS. Predicting who will have asthma at school age among preschool children. J Allergy Clin Immunol 2012; 130:325-31.
14. Fouzas S, Brand PL. Predicting persistence of asthma in preschool wheezers: crystal balls or muddy waters? Paediatr Respir Rev 2013; 14:46-52.
15. Bisgaard H, Jensen SM, Bonnelykke K. Interaction between asthma and lung function growth in early life. Am J Respir Crit Care Med 2012; 185:1183-9.
16. Turner SW, Palmer LJ, Rye PJ et al. The relationship between infant airway function, childhood airway responsiveness, and asthma. Am J Respir Crit Care Med 2004; 169:921-7.
17. Haland G, Carlsen KC, Sandvik L et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med 2006; 355:1682-9.
18. Collins SA, Pike KC, Inskip HM et al. Validation of novel wheeze phenotypes using longitudinal airway function and atopic sensitization data in the first 6 years of life: evidence from the Southampton Women's survey. Pediatr Pulmonol 2013; 48:683-92.
19. van der Gugten AC, Uiterwaal CS, van Putte-Katier N, Koopman M, Verheij TJ, van der Ent CK. Reduced neonatal lung function and wheezing illnesses during the first 5 years of life. Eur Respir J 2013; 42:107-15.
20. Caudri D, Wijga AH, Hoekstra MO et al. Prediction of asthma in symptomatic preschool children using exhaled nitric oxide. Rint and specific IgE. Thorax 2010; 65:801-7.
21. van de Kant KD, Jansen MA, Klaassen EM et al. Elevated inflammatory markers at preschool age precede persistent wheezing at school age. Pediatr Allergy Immunol 2012; 23:259-64.
22. Lowe LA, Simpson A, Woodcock A et al. Wheeze phenotypes and lung function in preschool children. Am J Respir Crit Care Med 2005; 171:231-7.
23. Turner SW, Young S, Goldblatt J, Landau LI, Le Souef PN. Childhood asthma and increased airway responsiveness: a relationship that begins in infancy. Am J Respir Crit Care Med 2009; 179:98-104.
24. Morgan WJ, Stern DA, Sherrill DL et al. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am J Respir Crit Care Med 2005; 172:1253-8.
25. Sears MR, Greene JM, Willan AR et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349:1414-22.
26. Barbato A, Turato G, Baraldo S et al. Airway inflammation in childhood asthma. Am J Respir Crit Care Med 2003; 168:798-803.
27. Payne DN, Rogers AV, Adelroth E et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003; 167:78-82.
28. Saglani S, Payne DN, Zhu J et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007; 176:858-64.
29. Saglani S, Malmstrom K, Pelkonen AS et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005; 171:722-7.
30. Malmstrom K, Pelkonen AS, Malmberg LP et al. Lung function, airway remodelling and inflammation in symptomatic infants: outcome at 3 years. Thorax 2011; 66:157-62.
31. Sonnappa S, Bastardo CM, Saglani S, Bush A, Aurora P. Relationship between past airway pathology and current lung function in preschool wheezers. Eur Respir J 2011; 38:1431-6.
32. O'Reilly R, Ullmann N, Irving S et al. Increased airway smooth muscle in preschool wheezers who have asthma at school age. J Allergy Clin Immunol 2013; 131:1024-32, 32 e1-16.
33. Bush A. How early do airway inflammation and remodeling occur? Allergol Int 2008; 57:11-9.
34. Marguet C, Jouen-Boedes F, Dean TP, Warner JO. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough, or cystic fibrosis. Am J Respir Crit Care Med 1999; 159:1533-40.
35. Le Bourgeois M, Goncalves M, Le Clainche L et al. Bronchoalveolar cells in children < 3 years old with severe recurrent wheezing. Chest 2002; 122:791-7.
36. De Schutter I, Dreesman A, Soetens O et al. In young children, persistent wheezing is associated with bronchial bacterial infection: a retrospective analysis. BMC Pediatr 2012; 12:83.
37. Schwerk N, Brinkmann F, Soudah B, Kabesch M, Hansen G. Wheeze in preschool age is associated with pulmonary bacterial infection and resolves after antibiotic therapy. PLoS ONE 2011; 6:e27913.
38. Marguet C, Dean TP, Warner JO. Soluble intercellular adhesion molecule-1 (sICAM-1) and interferon-gamma in bronchoalveolar lavage fluid from children with airway diseases. Am J Respir Crit Care Med 2000; 162:1016-22.
39. Hauk PJ, Krawiec M, Murphy J et al. Neutrophilic airway inflammation and association with bacterial lipopolysaccharide in children with asthma and wheezing. Pediatr Pulmonol 2008; 43:916-23.
40. Marguet C, Dean TP, Basuyau JP, Warner JO. Eosinophil cationic protein and interleukin-8 levels in bronchial lavage fluid from children with asthma and infantile wheeze. Pediatr Allergy Immunol 2001; 12:27-33.
41. Meyers DA, Bleecker ER, Holloway JW, Holgate ST. Asthma genetics and personalised medicine. Lancet Respir Med 2014; 2:405-15.
42. Dijk FN, de Jongste JC, Postma DS, Koppelman GH. Genetics of onset of asthma. Curr Opin Allergy Clin Immunol 2013; 13:193-202.
43. Martinez FD, Vercelli D. Asthma. Lancet 2013; 382:1360-72.
44. Klaassen EM, van de Kant KD, Jobsis Q et al. Integrative genomic analysis identifies a role for intercellular adhesion molecule 1 in childhood asthma. Pediatr Allergy Immunol 2014; 25:166-72.
45. Sly PD, Boner AL, Bjorksten B et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet 2008; 372:1100-6.
46. Sherrill DL, Stein R, Halonen M, Holberg CJ, Wright A, Martinez FD. Total serum IgE and its association with asthma symptoms and allergic sensitization among children. J Allergy Clin Immunol 1999; 104:28-36.
47. Illi S, von Mutius E, Lau S et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006; 368:763-70.
48. Simpson A, Soderstrom L, Ahlstedt S, Murray CS, Woodcock A, Custovic A. IgE antibody quantification and the probability of wheeze in preschool children. J Allergy Clin Immunol 2005; 116:744-9.
49. Lazic N, Roberts G, Custovic A et al. Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts. Allergy 2013; 68:764-70.
50. Rhodes HL, Thomas P, Sporik R, Holgate ST, Cogswell JJ. A birth cohort study of subjects at risk of atopy: twenty-two-year follow-up of wheeze and atopic status. Am J Respir Crit Care Med 2002; 165:176-80.
51. Kotaniemi-Syrjanen A, Reijonen TM, Romppanen J, Korhonen K, Savolainen K, Korppi M. Allergen-specific immunoglobulin E antibodies in wheezing infants: the risk for asthma in later childhood. Pediatrics 2003; 111:e255-61.
52. Kotaniemi-Syrjanen A, Reijonen TM, Korhonen K, Korppi M. Wheezing requiring hospitalization in early childhood: predictive factors for asthma in a six-year follow-up. Pediatr Allergy Immunol 2002; 13:418-25.
53. Hyvarinen MK, Kotaniemi-Syrjanen A, Reijonen TM, Piippo-Savolainen E, Korppi M. Eosinophil activity in infants hospitalized for wheezing and risk of persistent childhood asthma. Pediatr Allergy Immunol 2010; 21:96-103.
54. Just J, Nicoloyanis N, Chauvin M, Pribil C, Grimfeld A, Duru G. Lack of eosinophilia can predict remission in wheezy infants? Clin Exp Allergy 2008; 38:767-73.
55. Karakoc F, Remes ST, Martinez FD, Wright AL. The association between persistent eosinophilia and asthma in childhood is independent of atopic status. Clin Exp Allergy 2002; 32:51-6.
56. Koh GC, Shek LP, Goh DY, Van Bever H, Koh DS. Eosinophil cationic protein: is it useful in asthma? A systematic review. Respir Med 2007; 101:696-705.
57. Stern DA, Guerra S, Halonen M, Wright AL, Martinez FD. Low IFN-gamma production in the first year of life as a predictor of wheeze during childhood. J Allergy Clin Immunol 2007; 120:835-41.
58. Contreras JP, Ly NP, Gold DR et al. Allergen-induced cytokine production, atopic disease, IgE, and wheeze in children. J Allergy Clin Immunol 2003; 112:1072-7.
59. Rothers J, Halonen M, Stern DA et al. Adaptive cytokine production in early life differentially predicts total IgE levels and asthma through age 5 years. J Allergy Clin Immunol 2011; 128:397-402 e2.
60. Sarria EE, Mattiello R, Yao W et al. Atopy, cytokine production, and airway reactivity as predictors of pre-school asthma and airway responsiveness. Pediatr Pulmonol 2014; 49:132-9.
61. Borrego LM, Arroz MJ, Videira P et al. Regulatory cells, cytokine pattern and clinical risk factors for asthma in infants and young children with recurrent wheeze. Clin Exp Allergy 2009; 39:1160-9.
62. Klaassen EM, Van de Kant KD, Soeteman M et al. CD14/TLR interact with bacteria and regulatory T-cells in development of childhood asthma. Eur Respir J 2014; 44:799-802.
63. Reubsaet LL, Meerding J, de Jager W et al. Plasma chemokines in early wheezers predict the development of allergic asthma. Am J Respir Crit Care Med 2013; 188:1039-40.
64. Lex C, Payne DN, Zacharasiewicz A et al. Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern. Pediatr Pulmonol 2005; 39:318-24.
65. Gibson PG, Simpson JL, Hankin R, Powell H, Henry RL. Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma. Thorax 2003; 58:116-21.
66. Mussaffi H, Fireman EM, Mei-Zahav M, Prais D, Blau H. Induced sputum in the very young: a new key to infection and inflammation. Chest 2008; 133:176-82.
67. Gaillard EA, Grigg J, Tellabati A, McNally T, Whittaker A, Beardsmore CS. Isolation of cells from the lower airways in infants with wheeze by sputum induction. Eur Respir J 2013; 41:483-5.
68. Gore C, Peterson CG, Kissen P et al. Urinary eosinophilic protein X, atopy, and symptoms suggestive of allergic disease at 3 years of age. J Allergy Clin Immunol 2003; 112:702-8.
69. Chawes BL, Bonnelykke K, Bisgaard H. Elevated eosinophil protein X in urine from healthy neonates precedes development of atopy in the first 6 years of life. Am J Respir Crit Care Med 2011; 184:656-61.
70. Oommen A, McNally T, Grigg J. Eosinophil activation and preschool viral wheeze. Thorax 2003; 58:876-9.
71. Oymar K, Havnen J, Halvorsen T, Bjerknes R. Eosinophil counts and urinary eosinophil protein X in children hospitalized for wheezing during the first year of life: prediction of recurrent wheezing. Acta Paediatr 2001; 90:843-9.
72. Tauber E, Halmerbauer G, Frischer T et al. Urinary eosinophil protein X in children: the relationship to asthma and atopy and normal values. Allergy 2000; 55:647-52.
73. Nwokoro C, Pandya H, Turner S et al. Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial. Lancet Respir Med 2014; 2:796-803.
74. Barnes PJ, Dweik RA, Gelb AF et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010; 138:682-92.
75. Malmberg LP, Pelkonen AS, Haahtela T, Turpeinen M. Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax 2003; 58:494-9.
76. Moeller A, Diefenbacher C, Lehmann A et al. Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms. J Allergy Clin Immunol 2008; 121:705-9.
77. Brussee JE, Smit HA, Kerkhof M et al. Exhaled nitric oxide in 4-year-old children: relationship with asthma and atopy. Eur Respir J 2005; 25:455-61.
78. Oh MA, Shim JY, Jung YH et al. Fraction of exhaled nitric oxide and wheezing phenotypes in preschool children. Pediatr Pulmonol 2013; 48:563-70.
79. Elliott M, Heltshe SL, Stamey DC, Cochrane ES, Redding GJ, Debley JS. Exhaled nitric oxide predicts persistence of wheezing, exacerbations, and decline in lung function in wheezy infants and toddlers. Clin Exp Allergy 2013; 43:1351-61.
80. Debley JS, Stamey DC, Cochrane ES, Gama KL, Redding GJ. Exhaled nitric oxide, lung function, and exacerbations in wheezy infants and toddlers. J Allergy Clin Immunol 2010; 125:1228-34 e13.
81. Singer F, Luchsinger I, Inci D et al. Exhaled nitric oxide in symptomatic children at preschool age predicts later asthma. Allergy 2013; 68:531-8.
82. Savenije OE, Granell R, Caudri D et al. Comparison of childhood wheezing phenotypes in 2 birth cohorts: ALSPAC and PIAMA. J Allergy Clin Immunol 2011; 127:1505-12 e14.
83. van der Valk RJ, Caudri D, Savenije O et al. Childhood wheezing phenotypes and FeNO in atopic children at age 8. Clin Exp Allergy 2012; 42:1329-36.
84. Miekisch W, Schubert JK, Noeldge-Schomburg GF. Diagnostic potential of breath analysis-focus on volatile organic compounds. Clin Chim Acta 2004; 347:25-39.
85. van de Kant KD, van der Sande LJ, Jobsis Q, van Schayck OC, Dompeling E. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review. Respir Res 2012; 13:117.
86. Fens N, van der Schee MP, Brinkman P, Sterk PJ. Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions. Clin Exp Allergy 2013; 43:705-15.
87. Caldeira M, Barros AS, Bilelo MJ, Parada A, Camara JS, Rocha SM. Profiling allergic asthma volatile metabolic patterns using a headspace-solid phase microextraction/gas chromatography based methodology. J Chromatogr A 2011; 1218:3771-80.
88. Caldeira M, Perestrelo R, Barros AS et al. Allergic asthma exhaled breath metabolome: a challenge for comprehensive two-dimensional gas chromatography. J Chromatogr A 2012; 1254:87-97.
89. Dallinga JW, Robroeks CM, van Berkel JJ et al. Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children. Clin Exp Allergy 2010; 40:68-76.
90. van de Kant KD, van Berkel JJ, Jobsis Q et al. Exhaled breath profiling in diagnosing wheezy preschool children. Eur Respir J 2013; 41:183-8.
91. Smolinska A, Klaassen EM, Dallinga JW et al. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children. PLoS ONE 2014; 9:e95668.
92. Thomas PS, Lowe AJ, Samarasinghe P et al. Exhaled breath condensate in pediatric asthma: promising new advance or pouring cold water on a lot of hot air? a systematic review. Pediatr Pulmonol 2013; 48:419-42.
93. Rosias PP, Robroeks CM, van de Kant KD et al. Feasibility of a new method to collect exhaled breath condensate in pre-school children. Pediatr Allergy Immunol 2010; 21:e235-44.
94. von Jagwitz M, Pessler F, Akmatov M, Li J, Range U, Vogelberg C. Reduced breath condensate pH in asymptomatic children with prior wheezing as a risk factor for asthma. J Allergy Clin Immunol 2011; 128:50-5.
95. Klaassen EM, van Kant KD, Jöbsis Q et al. Symptoms, but not a biomarker response to inhaled corticosteroids, predict asthma in preschool children with recurrent wheeze. Mediators Inflamm 2012; 2012:162571.
96. Horvath I, Hunt J, Barnes PJ et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26:523-48.
97. Bloemen K, Koppen G, Govarts E et al. Application of non-invasive biomarkers in a birth cohort follow-up in relation to respiratory health outcome. Biomarkers 2010; 15:583-93.
98. van de Kant KD, Koers K, Rijkers GT et al. Can exhaled inflammatory markers predict a steroid response in wheezing preschool children? Clin Exp Allergy 2011; 41:1076-83.
99. Bacharier LB, Guilbert TW, Zeiger RS et al. Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. J Allergy Clin Immunol 2009; 123:1077-82, 82 e1-5.
100. Campusano L, Pastenes M, Fontecilla C, Escalona J, Salazar C, Castro-Rodriguez JA. Response to budesonide among atopic and non-atopic infants/preschoolers with recurrent wheezing. Allergol Immunopathol (Madr) 2010; 38:31-6.
101. Jartti T, Lehtinen P, Vanto T et al. Atopic characteristics of wheezing children and responses to prednisolone. Pediatr Pulmonol 2007; 42:1125-33.
102. Rabinovitch N, Graber NJ, Chinchilli VM et al. Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma. J Allergy Clin Immunol 2010; 126:545-51 e1-4.
103. Rogers AJ, Tantisira KG, Fuhlbrigge AL et al. Predictors of poor response during asthma therapy differ with definition of outcome. Pharmacogenomics 2009; 10:1231-42.
104. Ducharme FM, Zemek R, Gravel J et al. Determinants Of Oral corticosteroid Responsiveness in Wheezing Asthmatic Youth (DOORWAY): protocol for a prospective multicentre cohort study of children with acute moderate-to-severe asthma exacerbations. BMJ Open 2014; 4:e004699.
105. Perin P, Potocnik U. Polymorphisms in recent GWA identified asthma genes CA10, SGK493, and CTNNA3 are associated with disease severity and treatment response in childhood asthma. Immunogenetics 2014; 66:143-51.
106. Guilbert TW, Morgan WJ, Krawiec M et al. The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network. Control Clin Trials 2004; 25:286-310.
107. Puntmann VO. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease. Postgrad Med J 2009; 85:538-45.
108. Mischak H, Ioannidis JP, Argiles A et al. Implementation of proteomic biomarkers: making it work. Eur J Clin Invest 2012; 42:1027-36.
109. Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003; 326:41-4.